- Home
- EDSA vs BTOG Comparison
EDSA vs BTOG Comparison
Compare EDSA & BTOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- BTOG
- Stock Information
- Founded
- EDSA 2015
- BTOG 2018
- Country
- EDSA Canada
- BTOG Singapore
- Employees
- EDSA N/A
- BTOG N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- BTOG Finance: Consumer Services
- Sector
- EDSA Health Care
- BTOG Finance
- Exchange
- EDSA Nasdaq
- BTOG Nasdaq
- Market Cap
- EDSA 11.0M
- BTOG 11.0M
- IPO Year
- EDSA N/A
- BTOG 2019
- Fundamental
- Price
- EDSA $2.09
- BTOG $1.37
- Analyst Decision
- EDSA Strong Buy
- BTOG
- Analyst Count
- EDSA 1
- BTOG 0
- Target Price
- EDSA $21.00
- BTOG N/A
- AVG Volume (30 Days)
- EDSA 50.3K
- BTOG 126.1K
- Earning Date
- EDSA 12-13-2024
- BTOG 01-01-0001
- Dividend Yield
- EDSA N/A
- BTOG N/A
- EPS Growth
- EDSA N/A
- BTOG N/A
- EPS
- EDSA N/A
- BTOG N/A
- Revenue
- EDSA N/A
- BTOG $7,088,763.00
- Revenue This Year
- EDSA N/A
- BTOG N/A
- Revenue Next Year
- EDSA N/A
- BTOG N/A
- P/E Ratio
- EDSA N/A
- BTOG N/A
- Revenue Growth
- EDSA N/A
- BTOG 214.61
- 52 Week Low
- EDSA $2.09
- BTOG $1.28
- 52 Week High
- EDSA $6.46
- BTOG $9.71
- Technical
- Relative Strength Index (RSI)
- EDSA 19.32
- BTOG 32.23
- Support Level
- EDSA $2.26
- BTOG $1.38
- Resistance Level
- EDSA $2.44
- BTOG $2.29
- Average True Range (ATR)
- EDSA 0.26
- BTOG 0.28
- MACD
- EDSA -0.06
- BTOG -0.04
- Stochastic Oscillator
- EDSA 0.00
- BTOG 8.91
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions.